Document is current
Any future updates will be listed below
-
Authors
Palandri, Francesca
Branzanti, F.
Venturi, M.
Dedola, A.
Fontana, G.
Loffredo, M.
Patuelli, A.
Ottaviani, E.
Bersani, M.
Reta, M.
Addimanda, O.
Vicennati, V.
Vianelli, N.
Cavo, M.
-
Funding
Funding for this research was provided by:
Alma Mater Studiorum - Università di Bologna
- License Information
-
More Information
Article History
Received: 20 March 2024
Accepted: 14 May 2024
First Online: 21 May 2024
Declarations
:
: Michele Cavo acted as consultant and received honoraria from Jannsen, BMS Celgene, SanoFI, GlaxoSmithKline, Takeda, Amgen, Oncopeptides, AbbVie, Karyopharm, and Adaptive; Francesca Palandri had consultancy and honoraria from Novartis, Celgene, AOP, Sierra Oncology and CTI; all other authors have no conflicts to declare.
